MLYSMineralys Therapeutics Inc. Common Stock
25.65USD-4.82%Mkt Cap: 2.26B $P/E: —3d ago
Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. It is developing lorundrostat, a proprietary, orally administered,…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap2.26B $
Enterprise Value1.71B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-154.65M $
Revenue/Share—
Last Price25.65 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees76
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.30
PEG—
EV/EBITDA-4.62
EV/Revenue—
P/S—
P/B3.33
EPS (TTM)-4.01
EPS (Forward)-2.50
52W Range
14.2634% of range47.65
52W High47.65 USD
52W Low14.26 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-23.91%
ROA-23.37%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-142.42M $
CapEx (TTM)15.00K $
FCF Margin—
FCF Yield-9.00%
Net Debt-563.79M $
Net Debt/EBITDA1.52
Balance Sheet
Debt/Equity17.72
Current Ratio34.46
Quick Ratio34.24
Book Value/Sh7.739 USD
Cash/Share7.481 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)48.50 USD
Upside (mean)+89.1%
Target Range30.00 USD – 56.00 USD
$30.00+89.1% to mean$56.00
# Analysts8
Ownership
Shares Out.88.16M
Float66.42M
Insiders0.67%
Institutions117.68%
Short Interest
Short Ratio11.0d
Short % Float12.65%
Short % Out.10.56%
Shares Short9.31M
Short (prev mo.)11.10M
Technical
SMA 5026.61 (-3.6%)
SMA 20030.46 (-15.8%)
Beta0.68
S&P 52W Chg18.16%
Avg Vol (30d)697.51K
Avg Vol (10d)878.92K
Technical Indicators
RSI (14)42.6
MACD-0.1906
MACD Signal-0.1104
MACD Hist.-0.0802
BB Upper27.82 USD
BB Middle26.58 USD
BB Lower25.33 USD
BB Width9.37%
ATR (14)1.253 USD
Vol Ratio (20d)0.96x